Lead Dosing Session Monitor

Adams Clinical•Boston, MA

3d•$60 - $70•Hybrid

About The Position

Join Us in Shaping the Future of Clinical Research Adams Clinical is a leading clinical trial site network committed to accelerating the development of life-changing medicines. Our mission is simple: deliver uncompromising data quality, safety, and diverse enrollment to advance healthcare. Our vision is to set the gold standard for clinical trial excellence. We believe our people make the difference. Guided by our core values—Scientific Rigor, Operational Excellence, Commitment to Sponsors and Participants, and Authentic Collaboration—we create an environment where meaningful work drives meaningful change. At Adams Clinical, you’ll find: A culture of respect, transparency, and continuous improvement Opportunities for professional growth and learning A team dedicated to improving lives through innovation and integrity If you’re passionate about making an impact in clinical research and want to be part of a collaborative, mission-driven organization, we’d love to have you on our team. Job Role We are seeking a Part-Time Psychedelic Dosing Monitor / Therapist to support clinical trials focused on psychedelic research for individuals with depression, anxiety, and other mood disorders at one or more of our research site locations.

Requirements

Licensed mental health professionals in Massachusetts, New York, Pennsylvania, or Texas (e.g., PsyD, PhD, LCSW, LMSW, LMHC, LMFT) with the ability to provide psychotherapy in compliance with state regulations.
Significant experience providing psychotherapy to individuals with depression, anxiety, and other mood disorders.
Ability to meet fixed scheduling expectations, including consistent on-site availability.
Final candidate must be approved by both Adams Clinical and the study sponsor.
Therapists are expected to maintain consistent availability 3 days per week for participant-facing responsibilities, including pre-dose preparations, monitoring during dosing sessions, and post-dose follow-ups. Three-day availability must be either Monday-Wednesday or Tuesday-Thursday.
Scheduling will be based on study volume, participant availability, and internal priorities and requires dependable adherence to assigned days.
The majority of participant visits will be conducted on-site, with some remote participant visits.
Therapists must be willing to learn and adhere to ICH-GCP standards.
Additional responsibilities include administrative tasks, onboarding, and study-related training, and other tasks as assigned

Nice To Haves

Prior training in the administration of therapy within industry-sponsored psychedelic trials (e.g., Compass, Cybin, MindMed, Atai) is preferred.

Responsibilities

Serve as Lead Study Therapist in clinical trials for depression, anxiety, and other mood disorders
Complete study-sponsored therapist training
Provide support to participants throughout the clinical trial, in alignment with the study protocol and the training guidelines provided.
Collaborate as needed with the team of clinicians managing the participants’ participation in the study